The Effect of Platelet Rich Plasma on Non-scarring Alopecia
Status:
Completed
Trial end date:
2019-06-03
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the clinical efficacy of platelet rich plasma (PRP)
injections for non-scaring alopecia in women. A randomized, placebo-controlled clinical trial
will be performed where patients with non-scarring alopecia will either receive injections of
their own PRP or injections of normal saline (placebo). Patients in the treatment group
(Group A) will have a small amount of their own blood drawn and have their PRP injected into
their scalp four times. The injections will be given at weeks zero, four, eight, and twenty
four. The placebo group (Group B) will be given the same schedule but will receive sham
injections only and will not have any blood drawn. Both groups will have clinical data
collected at all visits, including a screening visit before enrollment and a final assessment
visit at week 40, for a total of 6 study visits per patient. Data collection will include
representative photographs of the scalp and measurements of hair thickness. The results from
the two groups will then be compared.
In summary, all study participants will have a screening visit before enrollment, four study
visits for sub-dermal scalp injections, and one final assessment visit at week 40.